Keyword

ASDAS

Description: ASDAS, or Ankylosing Spondylitis Disease Activity Score, is a composite clinical measure used to assess disease activity in axial spondyloarthritis.

Primary topic: Spondyloarthritis Studies and Treatments (94%)

OpenAlex ID: keywords/asdas

Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis

2008 · C Lukas, R Landewé, et al. · Annals of the Rheumatic Diseases · 1,066

Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

2010 · Pedro Machado, Robert Landewé, et al. · Annals of the Rheumatic Diseases · 806

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

2017 · Josef S Smolen, Monika Schöls, et al. · Annals of the Rheumatic Diseases · 684

PDF

ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis

2008 · D van der Heijde, E Lie, et al. · Annals of the Rheumatic Diseases · 634

Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)

2012 · Joachim Sieper, Désirée van der Heijde, et al. · Annals of the Rheumatic Diseases · 536

PDF

Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS‐G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ‐S)

2011 · Jane Zochling · Arthritis Care & Research · 349

Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort

2014 · Sofia Ramiro, Désirée van der Heijde, et al. · Annals of the Rheumatic Diseases · 346

PDF

Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis

2012 · Féline Kroon, Robert Landewé, et al. · Annals of the Rheumatic Diseases · 261

PDF

TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort

2017 · Christoph Molnar, Almut Scherer, et al. · Annals of the Rheumatic Diseases · 260

PDF

Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)

2014 · Denis Poddubnyy, Kay-Geert A Hermann, et al. · Annals of the Rheumatic Diseases · 260

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial

2018 · Désirée van der Heijde, Xenofon Baraliakos, et al. · The Lancet · 259

PDF

Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study

2011 · Suzanne Arends, Elisabeth Brouwer, et al. · Arthritis Research & Therapy · 228

PDF

The prevalence of depression in axial spondyloarthritis and its association with disease activity: a systematic review and meta-analysis

2018 · Sizheng Zhao, Daniel Thong, et al. · Arthritis Research & Therapy · 160

PDF

Tumor Necrosis Factor α Inhibition in Radiographic and Nonradiographic Axial Spondyloarthritis: Results From a Large Observational Cohort

2013 · Adrian Ciurea, Almut Scherer, et al. · Arthritis & Rheumatism · 154

Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab

2012 · Chamaida Plasencia, Dora Pascual-Salcedo, et al. · Annals of the Rheumatic Diseases · 123

Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor α inhibitors

2009 · Susanne Juhl Pedersen, Inge Juul Sørensen, et al. · Annals of the Rheumatic Diseases · 120

Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature

2023 · Désirée van der Heijde, Anna Molto, et al. · Annals of the Rheumatic Diseases · 118

PDF

Efficacy and safety of adalimumab in Chinese adults with active ankylosing spondylitis: results of a randomised, controlled trial

2013 · Feng Huang, Jieruo Gu, et al. · Annals of the Rheumatic Diseases · 116

ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors

2011 · Susanne Juhl Pedersen, Inge Juul Sørensen, et al. · Annals of the Rheumatic Diseases · 116

Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies

2021 · Philip J Mease, Philip S Helliwell, et al. · The Lancet Rheumatology · 105

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial

2021 · Anna Molto, Clementina López-Medina, et al. · Annals of the Rheumatic Diseases · 104

PDF

MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor

2012 · Pedro Machado, Robert B M Landewé, et al. · Annals of the Rheumatic Diseases · 104

A Fifty‐Two–Week, Randomized, Placebo‐Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis

2019 · Atul Deodhar, Lianne S. Gensler, et al. · Arthritis & Rheumatology · 102

PDF

The Sex Influence on Response to Tumor Necrosis Factor-α Inhibitors and Remission in Axial Spondyloarthritis

2017 · Ennio Lubrano, Fabio Massimo Perrotta, et al. · The Journal of Rheumatology · 94

PDF

Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis

2017 · Raphael Micheroli, Monika Hebeisen, et al. · Arthritis Research & Therapy · 90

PDF

Works count: 1,130

Citation count: 13,020